Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/06 15:11 | 3/14/05 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David H | CT | DT | P.adm | 255 | 0.0721 | 0 | 3,532 | 56 | 9,840 | M | |||||||||||||||
12/22/06 11:55 | 12/19/06 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Chin Sally | MA | D | P.d | 15 | 0.0600 | 0 | 250 | 79 | 568 | D | |||||||||||||||
12/21/06 15:18 | 3/14/05 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David H | CT | D | P.dm | 255 | 0.0721 | 0 | 3,532 | 71 | 8,520 | M | |||||||||||||||
9/29/05 11:41 | 1/28/05 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Furtado Edward D | MA | DO | VP of Op | S.dm | -40 | 2.00 | 0 | -20 | -2 | 1,120 | D | ||||||||||||||
9/29/05 11:39 | 11/29/04 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Chatterjee Nilu Prasad | MA | DOT | VP of Re | S.dm | -104 | 2.60 | 0 | -40 | -1 | 4,450 | I | ||||||||||||||
9/29/05 11:36 | 11/29/04 | INTP | Health | Diagn | In Vitro & In Vivo Diagnostic | Chatterjee Chinmay | MA | DOT | P | S.dm | -104 | 2.60 | 0 | -40 | -1 | 4,450 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |